Safety and Efficacy of MRI-Based Selection for Recombinant Tissue Plasminogen Activator Treatment: Responder Analysis of Outcome in the 3-Hour Time Window

Publisher： Karger

E-ISSN： 1421-9786|27|3|223-229

ISSN： 1015-9770

Source： Cerebrovascular Diseases, Vol.27, Iss.3, 2009-01, pp. : 223-229

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Successful treatment of fulminant pneumococcal sepsis with recombinant tissue plasminogen activator

By Akol H.   Boon E.S.   van Haren F.M.P.   van der Hoeven J.G.  

European Journal of Internal Medicine, Vol. 13, Iss. 6, 2002-09 ,pp. : 389-391

Elsevier

Access to resources Recommend Favorite

Recanalization within One Hour after Intravenous Tissue Plasminogen Activator Is Associated with Favorable Outcome in Acute Stroke Patients

By  

European Neurology, Vol. 63, Iss. 6, 2010-06 ,pp. : 331-336

Karger

Access to resources Recommend Favorite

Negative Fluid-Attenuated Inversion Recovery- Based Intravenous Thrombolysis Using Recombinant Tissue Plasminogen Activator in Acute Stroke Patients with Unknown Onset Time

By  

Cerebrovascular Diseases Extra, Vol. 3, Iss. 1, 2013-03 ,pp. : 35-45

Karger

Access to resources Recommend Favorite

Clinical and MRI Scale to Predict Very Poor Outcome in Tissue Plasminogen Activator Patients

By  

European Neurology, Vol. 65, Iss. 5, 2011-04 ,pp. : 291-295

Karger

Access to resources Recommend Favorite

Vascular Aphasia Outcome after Intravenous Recombinant Tissue Plasminogen Activator Thrombolysis for Ischemic Stroke

By  

European Neurology, Vol. 71, Iss. 5-6, 2014-02 ,pp. : 288-295

Karger

Access to resources Recommend Favorite